Edesa Biotech is very risky given 1 month investment horizon. Edesa Biotech secures Sharpe Ratio (or Efficiency) of 0.15, which denotes the company had 0.15% of return per unit of risk over the last month. Our standpoint towards predicting the volatility of a stock is to use Edesa Biotech market data together with company specific technical indicators. We were able to analyze twenty-eight different technical indicators, which can help you to evaluate if expected returns of 2.7% are justified by taking the suggested risk. Use Edesa Biotech Downside Deviation of 7.32, mean deviation of 8.81, and Coefficient Of Variation of 664.46 to evaluate company specific risk that cannot be diversified away.